- Home
- MESA vs MAIA Comparison
MESA vs MAIA Comparison
Compare MESA & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- MAIA
- Stock Information
- Founded
- MESA 1982
- MAIA 2018
- Country
- MESA United States
- MAIA United States
- Employees
- MESA N/A
- MAIA N/A
- Industry
- MESA Air Freight/Delivery Services
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- MAIA Health Care
- Exchange
- MESA Nasdaq
- MAIA Nasdaq
- Market Cap
- MESA 45.9M
- MAIA 46.7M
- IPO Year
- MESA 2018
- MAIA 2022
- Fundamental
- Price
- MESA $1.02
- MAIA $1.79
- Analyst Decision
- MESA
- MAIA
- Analyst Count
- MESA 0
- MAIA 0
- Target Price
- MESA N/A
- MAIA N/A
- AVG Volume (30 Days)
- MESA 156.6K
- MAIA 274.6K
- Earning Date
- MESA 05-20-2025
- MAIA 05-09-2025
- Dividend Yield
- MESA N/A
- MAIA N/A
- EPS Growth
- MESA N/A
- MAIA N/A
- EPS
- MESA N/A
- MAIA N/A
- Revenue
- MESA $424,030,000.00
- MAIA N/A
- Revenue This Year
- MESA $39.81
- MAIA N/A
- Revenue Next Year
- MESA N/A
- MAIA N/A
- P/E Ratio
- MESA N/A
- MAIA N/A
- Revenue Growth
- MESA N/A
- MAIA N/A
- 52 Week Low
- MESA $0.68
- MAIA $1.40
- 52 Week High
- MESA $1.89
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- MESA 48.00
- MAIA 47.79
- Support Level
- MESA $1.01
- MAIA $1.71
- Resistance Level
- MESA $1.05
- MAIA $1.85
- Average True Range (ATR)
- MESA 0.04
- MAIA 0.13
- MACD
- MESA -0.00
- MAIA -0.02
- Stochastic Oscillator
- MESA 50.00
- MAIA 25.64
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.